Price
Frequently asked questions
What is Certara's market capitalization?
What is the Earnings Per Share (EPS) for Certara?
What are the analyst ratings and target price for Certara's stock?
What is Certara's revenue over the trailing twelve months?
What is the EBITDA for Certara?
What is the free cash flow of Certara?
What is the 5-year beta of Certara's stock?
How many employees does Certara have, and what sector and industry does it belong to?
What is the free float of Certara's shares?
Financials
Market Cap
$1.75B5Y beta
1.52EPS (TTM)
-$0.194Free Float
120.45MRevenue (TTM)
$372.80MEBITDA (TTM)
$60.38MFree Cashflow (TTM)
$34.85MPricing
Analyst Ratings
The price target is $19.72 and the stock is covered by 11 analysts.
Buy
3
Hold
8
Sell
0
Information
Certara, Inc. is engaged in model-informed drug development. The Company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. It also develops scientific informatics software products used by the life sciences industry for in-silico research. It develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.
1,338
Software & Programming
Information Technology
Identifier
ISIN
Primary Ticker